<DOC>
	<DOCNO>NCT00684619</DOCNO>
	<brief_summary>The purpose study determine whether Nelarabine effective treatment patient T-ALL/NHL order achieve complete remission follow early stem cell transplantation .</brief_summary>
	<brief_title>506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia ( T-ALL )</brief_title>
	<detailed_description />
	<mesh_term>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>TALL ; TNHL age &gt; = 18 year cytological treatment failure / relapse molecular treatment failure / relapse promise therapy alternative approve medication available CNSmanifestation , require intrathecal therapy CNSradiation convulsive disease neurotoxicity &gt; grade III patient history write informed consent cytostatic therapy last 10 day pregnancy breastfeed effective contraception recovery toxicity previous chemotherapy except leukemia relate change like bone marrow suppression pathological transaminase liver manifestation Severe psychiatric illness uncontrolled severe cardiac disease infection active secondary neoplasm except skin cancer ( melanoma )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>